Stroud Energy Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (40)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
Article By: Benzinga
Sunday, January 2, 2022 5:00 PM EDT
Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. Here are the key catalysts that can sway biotech stocks in the unfolding week.
In this article: AZN, ANGO, STRO, IONS, XERS, BBIO, EWTX, AVTX, CING, NRSN
Read
Week In Review: Tasly Pharma Acquires Sutro ADC In $385 Million Deal
Article By: ChinaBio® Today
Saturday, January 1, 2022 2:45 PM EDT
Tasly Pharma acquired Greater China rights to an antibody-drug conjugate from Sutro Biopharma in a deal worth up to $385 million. Sutro will receive an upfront payment of $40 million and be eligible for $345 million in milestone payments.
In this article: 600535.SS, STRO, 2616.HK, 9939.HK, 2257.HK
Read
Week In Review: Hansoh Signs $456 Million Deal For SiRNA Products
Article By: ChinaBio® Today
Saturday, October 16, 2021 1:29 PM EDT
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to $450 million in milestones.
In this article: BMY, STRO, BGNE, ZLAB, TCON, TWST, 9939.HK, 3692.HK, 226950.KQ, 2256.HK
Read
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Article By: Benzinga
Sunday, November 29, 2020 4:14 PM EDT
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday. The week kickstarted with lukewarm news on the coronavirus vaccine front.
In this article: AZN, MRK, PFE, VNDA, MRNA, STRO, RVNC, IMV, BNTX, LQDA
Read
The Week Ahead In Biotech: Focus On Mallinckrodt FDA Decision, Conference Presentations
Article By: Benzinga
Sunday, September 6, 2020 2:22 PM EDT
After remaining steady in the first three sessions of the week ended September 4, biotech stocks pulled back along with the broader market in a tech-induced sell-off. Barring anything COVID-19-related, the news flow was fairly light.
In this article: JNJ, RHHBY, VRNA, LGND, AMRN, VYGR, STRO, MNK, AGTC, ATRA
Read
All Posts

Latest Tweets for $STRO

No tweets yet!

PARTNER HEADLINES